NHS National Generics Pharmaceuticals - Supply Chain Resilience

Se generará un resumen en la próxima visita.

Valor adjudicado

39.223.496 GBP

Fecha de adjudicación

01 de mayo de 2026

Fecha de publicación

01 de mayo de 2026

• Fresenius Kabi Limited
  35.010.320 GBP
• Brown and Burk UK Ltd
  35.010.320 GBP
• Jannsen-Cilag Limited
  35.010.320 GBP
• Accord UK Ltd
  35.010.320 GBP
• Ascend Laboratories
  35.010.320 GBP
• Aspire Pharma Limited
  35.010.320 GBP
• Cipla (EU) Limited
  35.010.320 GBP
• Hikma Pharmaceuticals International Ltd
  35.010.320 GBP
• MACARTHYS LABORATORIES LIMITED
  35.010.320 GBP
• Milpharm Limited
  35.010.320 GBP
• Sun Pharma UK Limited
  35.010.320 GBP
• Teva UK Limited
  35.010.320 GBP
• Viatris UK Healthcare Limited
  35.010.320 GBP
• Wockhardt UK Limited
  35.010.320 GBP
• Zentiva Pharma UK Limited
  35.010.320 GBP
• Glenmark Pharmaceuticals (Europe) Ltd
  35.010.320 GBP
• Amarox Limited
  35.010.320 GBP
• Baxter Healthcare Ltd
  35.010.320 GBP
• Aspire Pharma Limited
  4.213.176 GBP
• Milpharm Limited
  4.213.176 GBP
• Teva UK Limited
  4.213.176 GBP
• Wockhardt UK Limited
  4.213.176 GBP
• Zentiva Pharma UK Limited
  4.213.176 GBP
• Colonis Pharma Ltd
  4.213.176 GBP
• Crescent Pharma Limited
  4.213.176 GBP
• Day Lewis Medical Ltd
  4.213.176 GBP
• Ennogen Healthcare International Limited
  4.213.176 GBP
• G.L. Pharma UK Limited
  4.213.176 GBP
• Morningside Pharmaceuticals Ltd
  4.213.176 GBP
• Northumbria Pharma Limited
  4.213.176 GBP
• Selective Supplies Limited
  4.213.176 GBP
• Amarox Limited
  4.213.176 GBP

• Anuncio de adjudicación
  text/html · 01 de mayo de 2026